ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2962

Expression Profile of Chemokines Is Skewed to Th17/Th22 Recruitment in Circulation of Patients with Behcet’s Disease

Hidekata Yasuoka and Tsutomu Takeuchi, Keio University School of Medcine, Division of Rheumatology, Department of Internal Medicine, Tokyo, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Behcet's syndrome and chemokines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis - Poster III: Rarer Vasculitides

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Behcet’s disease (BD) is an inflammatory disease characterized by ocular, mucosal and skin lesions. However, the pathogenesis of BD is still unknown. Characteristics of histologic findings show granulocyte-dominant immune cell infiltration, suggesting dominancy of innate immune response or “inflammation-like immune response” rather than acquired immune response. Thus, BD is recently proposed to categorize as an autoinflammatory disease. To clarify the pathogenesis of BD and have an answer for activation status of immune system, levels of multiple chemokines in the circulating milieu were assessed as a reflection of the local production of chemokines for the recruitment of immune cells.

Methods: Twenty-seven patients with BD (12 active and 15 inactive patients) and 20 healthy controls were involved. Levels of chemokine in plasma were examined by enzyme-linked immunosorbent assay. Various chemokines were assessed, including RANTES (recruitment of general T cells), CX3CL1 (cytotoxic T cells, NK cells, gamma-delta T cells), MCP-1 (monocytes), CXCL9 (Th1 cells including Th1/Th17 cells, effector CD8+ cells), MIP3a (Th17)、CCL27 (Th22) to cover recruitment of various lymphocytes. Comparison between 2 groups was assessed by non-parametric Mann-Whitney U-test.

Results: Levels of circulating RANTES, CX3CL1, MCP-1, and CXCL9 were comparable in both groups, suggesting that recruitment of general T cells, monocytes, cytotoxic lymphocytes were not expected based on profiles of these chemokines. On the other hand, plasma concentration of MIP3a and CCL27 were higher in BD compared to healthy controls (MIP3a: 39.6 ± 54.3 versus 14.5 ± 8.9, P < 0.05, CCL27: 354.2 ± 150.6 versus 238.3 ± 155.5, P < 0.05, respectively), suggesting the association with recruitment of Th17 and Th22. Interestingly, levels of CCL20 was comparable between patients with active disease and those without, whereas CCL27 was higher in patients with inactive disease compared to those with active disease.

Conclusion: In patients with BD, expression profile of the chemokine in circulation is skewed rather than global upregulation, suggesting that pathophysiological process in BD is not a non-specific inflammation from the point of view of chemokines. Upregulation of CCL20 in BD patients and downregulation of CCL27 in active patients might associate with regulation of infiltration of Th17 or Th22 to the lesions, and with pathogenesis of BD.


Disclosure: H. Yasuoka, None; T. Takeuchi, None.

To cite this abstract in AMA style:

Yasuoka H, Takeuchi T. Expression Profile of Chemokines Is Skewed to Th17/Th22 Recruitment in Circulation of Patients with Behcet’s Disease [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/expression-profile-of-chemokines-is-skewed-to-th17th22-recruitment-in-circulation-of-patients-with-behcets-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expression-profile-of-chemokines-is-skewed-to-th17th22-recruitment-in-circulation-of-patients-with-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology